Watch this insightful webinar with Alok Tayi, PhD, Co-Founder and CEO of Vibe Bio,  on how AI is accelerating the business development process, helping executive teams move faster by making it easier to collect, manage, access, and evaluate drug assets, thus empowering them to conduct more thorough due diligence with the same resources.

In this session, you’ll gain valuable insights into:

• The increasing complexity of in-licensing: Why securing the right drug programs is more challenging than ever in today’s biopharma landscape.
• Transforming search & evaluation with AI: How artificial intelligence is reshaping the process, making it more efficient, accurate, and aligned with strategic goals.
• The synergy between scientific leadership and AI: How effective collaboration between executive leadership and AI analyses delivers optimal results in the in-licensing process.

You’ll also learn how VibeOne, Vibe Bio’s AI analysts platform, is streamlining program sourcing and due diligence to help accelerate your business development processes and enhance decision-making.